Cargando…
Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models
Huntington's disease (HD) is a fatal degenerative autosomal dominant neuropsychiatric disease that causes neuronal death and is characterized by progressive striatal and then widespread brain atrophy. Brain-derived neurotrophic factor (BDNF) is a lead candidate for the treatment of HD, as it ha...
Autores principales: | Pollock, Kari, Dahlenburg, Heather, Nelson, Haley, Fink, Kyle D, Cary, Whitney, Hendrix, Kyle, Annett, Geralyn, Torrest, Audrey, Deng, Peter, Gutierrez, Joshua, Nacey, Catherine, Pepper, Karen, Kalomoiris, Stefanos, D Anderson, Johnathon, McGee, Jeannine, Gruenloh, William, Fury, Brian, Bauer, Gerhard, Duffy, Alexandria, Tempkin, Theresa, Wheelock, Vicki, Nolta, Jan A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881765/ https://www.ncbi.nlm.nih.gov/pubmed/26765769 http://dx.doi.org/10.1038/mt.2016.12 |
Ejemplares similares
-
Developing stem cell therapies for juvenile and adult-onset Huntington’s disease
por: Fink, Kyle D, et al.
Publicado: (2015) -
Clinical trial perspective for adult and juvenile Huntington's disease using genetically-engineered mesenchymal stem cells
por: Deng, Peter, et al.
Publicado: (2016) -
Genetically Engineered Mesenchymal Stem Cells as a Proposed Therapeutic for Huntington’s Disease
por: Olson, Scott D., et al.
Publicado: (2011) -
Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical
limb ischemia
por: Beegle, Julie R, et al.
Publicado: (2016) -
A novel Huntington's disease mouse model to assess the role of neuroinflammation on disease progression and to develop human cell therapies
por: Dahlenburg, Heather, et al.
Publicado: (2021)